RE:RE:RE:Shareholders Agree, reading between the lines is not silent but rather screaming in your face. Golden parachutes issued at $.06 and negative eps? On the surface it makes no sense at all until you bring the bigger picture into clearer focus and hence a very loud and bullish indicator. Brazilian news is according to what we know so far is generic based but we have no idea what the new drug application is about except that it is a new drug that currently does not exist. I think it's a new cancer drug, a natural extension of scientific evidence in the field of oncology involving cannabinoids. All of the early presentations be it by Yolav Goladi or Dedi Meri had as their focal point cancer killed by cannabinoid compounds and extend the scientific work and evidence of that past into the present and hence my logical process saying the NDA is for cancer.
If, Then, logic. If the NDA is for a new cancer drug then it would substantiate the request by the NIH in writing to the DEA to remove it from Schedule 1 to Schedule 3 in conjunction with Biden being briefed and now granting pardons and admitting their prior approach was wrong.
For me those pieces connect very clearly and who got a tid bit of that info when volume surged to 1.66 million shares....information tends to be 'leaky' at best.